Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanexa | NANEXA | Mar 28, 2024 | 0.78 | +4.86 |
NanoCap Group B | NANOCB | Mar 28, 2024 | 5.35 | -3.60 |
Nanoform Finland | NANOFS | Mar 28, 2024 | 31.80 | +7.07 |
Nanologica | NICA | Mar 28, 2024 | 6.76 | +4.97 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | Mar 28, 2024 | 4 208.03 | +0.26 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | Mar 28, 2024 | 2 648.75 | +0.26 |
Nattaro Labs | NATTA | Mar 28, 2024 | 0.69 | +5.30 |
Navigo Invest AB | NAVIGOSTAM | Mar 28, 2024 | 4.18 | +1.21 |
Navigo Invest Pref | NAVIGOPREF | Mar 28, 2024 | 105.50 | -0.47 |
NAXS | NAXS | Mar 28, 2024 | 70.00 | +1.16 |
NCAB Group | NCAB | Mar 28, 2024 | 70.15 | -0.28 |
NCC A | NCCA | Mar 28, 2024 | 149.00 | 0.00 |
NCC B | NCCB | Mar 28, 2024 | 147.30 | -0.20 |
Nederman Holding | NMAN | Mar 28, 2024 | 175.50 | -1.13 |
NEL | NELO | Mar 28, 2024 | 4.76 | 0.00 |
Nelly Group | NELLY | Mar 28, 2024 | 17.60 | +2.03 |
Neobo Fastigheter | NEOBO | Mar 28, 2024 | 19.04 | -2.26 |
NeoDynamics | NEOD | Mar 28, 2024 | 0.95 | +0.21 |
Neola Medical | NEOLA | Mar 28, 2024 | 1.92 | +4.92 |
Nepa | NEPA | Mar 28, 2024 | 31.90 | 0.00 |
Net Insight B | NETIB | Mar 28, 2024 | 5.92 | -0.42 |
Netel | NETEL | Mar 28, 2024 | 11.30 | -0.44 |
NetJobs Group | NJOB | Mar 28, 2024 | 0.33 | 0.00 |
New Nordic Healthbrands | NNH | Mar 28, 2024 | 19.00 | 0.00 |
New Wave B | NEWAB | Mar 28, 2024 | 128.08 | +1.96 |
Newbury Pharmaceuticals | NEWBRY | Mar 28, 2024 | 3.74 | -2.60 |
News55 | N55 | Mar 28, 2024 | 2.59 | 0.00 |
Nexam Chemical Holding | NEXAM | Mar 28, 2024 | 3.29 | +2.81 |
Nexar Group | NXAR | Mar 28, 2024 | 0.23 | 0.00 |
NextCell Pharma AB | NXTCL | Mar 28, 2024 | 3.08 | -4.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.